Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Michael Burry Bets Against AI Giant Nvidia

Andreas Sommer by Andreas Sommer
November 14, 2025
in AI & Quantum Computing, Analysis, Semiconductors, Tech & Software
0
Nvidia Stock
0
SHARES
22
VIEWS
Share on FacebookShare on Twitter

A notable figure from the 2008 financial crisis has resurfaced with a significant bearish position. Michael Burry, the hedge fund manager famous for his profitable bet against the U.S. housing market, has established a substantial put options position against Nvidia during the third quarter. This move against the AI chip leader raises a critical question for investors: is this a prescient warning, or a miscalculation of a powerful technological trend?

Sector-Wide Sell-Off Drags Tech Shares Lower

The timing of Burry’s trade coincides with a notable downturn for the technology sector. On Friday, Nvidia shares declined by 3.6%, pushing the stock more than 10% below its record high from late October. This drop was part of a broader market retreat, with the Nasdaq Composite falling 2.29% and the S&P 500 dropping 1.66%.

Several factors are contributing to the current market weakness:

  • Rising skepticism regarding the sustainability of artificial intelligence expenditures
  • Stretched valuations among major technology companies
  • A more pessimistic outlook for U.S. interest rate policy
  • A market rotation away from growth stocks and into value-oriented assets

The situation is particularly acute for Nvidia, which now comprises approximately 8% of the S&P 500 and about 10% of the Nasdaq 100. Consequently, any significant movement in its stock price has a pronounced effect on the broader indices.

Scrutiny on the AI Investment Boom

Michael Burry is not a typical investor, and his track record commands attention. His decision to build a put position against Nvidia forces the market to confront an uncomfortable possibility: that the AI hype may be overextended. The sustainability of massive infrastructure spending by hyperscalers like Microsoft and Amazon is now under intense scrutiny. Can these corporations maintain their current aggressive investment pace?

Should investors sell immediately? Or is it worth buying Nvidia?

Market participants are increasingly demanding concrete evidence of profitability from AI investments, moving beyond mere growth narratives.

Quarterly Earnings Report Looms Large

Nvidia is scheduled to report its third-quarter financial results on November 19th. Wall Street anticipates earnings per share of $1.25, a 54% increase from the prior year, and revenue of $54.83 billion, representing 56% growth. However, the company’s forward guidance will likely be the most critical component of the report.

Analyst expectations have risen sharply; since May, revenue projections for fiscal year 2027 have been lifted by 15% to approximately $285 billion. Despite the recent share price weakness, some market experts remain optimistic. Oppenheimer raised its price target from $225 to $265, while Susquehanna lifted its target from $210 to $230. Both firms cited Nvidia’s enduring dominance in the AI chip market as the primary reason for their confidence.

The central question for investors remains: Is Michael Burry’s famous intuition correct once again, or has he underestimated the powerful, long-term momentum of the AI megatrend? The answer may become clear in a matter of days.

Ad

Nvidia Stock: Buy or Sell?! New Nvidia Analysis from February 7 delivers the answer:

The latest Nvidia figures speak for themselves: Urgent action needed for Nvidia investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Nvidia: Buy or sell? Read more here...

Tags: Nvidia
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

CrossFirst Bankshares Stock
Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock
Cyber Security

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026
Next Post
Tilray Stock

US Regulatory Shift Sends Tilray Shares into a Tailspin

Equillium Stock

Equillium Secures Financial Lifeline, Shares Advance on Strong Results

Cognex Stock

Cognex Shares: Navigating the Valuation Divide

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com